- Sweden
- /
- Real Estate
- /
- OM:WALL B
Swedish Exchange Growth Companies With Minimum 28% Insider Ownership
Reviewed by Simply Wall St
As global markets navigate through a mix of economic signals, with some regions showing signs of slowing while others display modest growth, the Swedish stock market remains a point of interest for investors looking for growth opportunities. In this context, companies with high insider ownership can be particularly appealing as they often indicate a strong alignment between company management and shareholder interests.
Top 10 Growth Companies With High Insider Ownership In Sweden
Name | Insider Ownership | Earnings Growth |
CTT Systems (OM:CTT) | 16.9% | 21.6% |
BioArctic (OM:BIOA B) | 35.1% | 50.9% |
Sileon (OM:SILEON) | 33.3% | 109.3% |
KebNi (OM:KEBNI B) | 37.8% | 90.4% |
edyoutec (NGM:EDYOU) | 14.6% | 63.1% |
Biovica International (OM:BIOVIC B) | 12.7% | 73.8% |
Calliditas Therapeutics (OM:CALTX) | 11.6% | 52.9% |
Egetis Therapeutics (OM:EGTX) | 17.6% | 98.2% |
Yubico (OM:YUBICO) | 37.5% | 43.4% |
SaveLend Group (OM:YIELD) | 24.9% | 103.4% |
We're going to check out a few of the best picks from our screener tool.
BioArctic (OM:BIOA B)
Simply Wall St Growth Rating: ★★★★★★
Overview: BioArctic AB (publ) focuses on developing biological drugs for central nervous system disorders, with a market capitalization of SEK 19.70 billion.
Operations: The company generates revenue primarily from its biotechnology segment, totaling SEK 252.21 million.
Insider Ownership: 35.1%
BioArctic, a Swedish biopharmaceutical company, is navigating a challenging phase with significant revenue decline and net losses as reported in Q1 2024. Despite this, the company's strategic focus on Alzheimer's treatment innovation remains strong, underscored by recent approvals in South Korea for Leqembi® and ongoing collaborative research with Eisai Co., Ltd. Analysts predict substantial future revenue growth (40.8% per year) and expect BioArctic to become profitable within three years, reflecting potential recovery and growth despite current financial setbacks.
- Get an in-depth perspective on BioArctic's performance by reading our analyst estimates report here.
- Our comprehensive valuation report raises the possibility that BioArctic is priced lower than what may be justified by its financials.
AB Sagax (OM:SAGA A)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: AB Sagax (ticker: OM:SAGA A) is a property company active in Sweden, Finland, France, Benelux, Spain, Germany, and other European countries with a market capitalization of approximately SEK 93.07 billion.
Operations: The company generates its revenue primarily through real estate rentals, amounting to SEK 4.47 billion.
Insider Ownership: 28.3%
AB Sagax, a Swedish real estate company, has recently raised €500 million through green bond issuances, signaling robust financial activity. Despite this influx, the company's debt is not well covered by operating cash flow. However, AB Sagax shows promising growth prospects with earnings expected to increase 33.4% annually and revenue forecasted to grow at 9.3% per year—both rates surpassing the Swedish market averages. This performance comes amidst a backdrop of high insider ownership but also shareholder dilution over the past year.
- Navigate through the intricacies of AB Sagax with our comprehensive analyst estimates report here.
- Our expertly prepared valuation report AB Sagax implies its share price may be too high.
Wallenstam (OM:WALL B)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Wallenstam AB (publ) is a property company based in Sweden, with a market capitalization of approximately SEK 32.43 billion.
Operations: The company generates its revenue primarily from two segments: Stockholm, which contributes SEK 920 million, and Gothenburg, with SEK 1.89 billion.
Insider Ownership: 35%
Wallenstam AB, a Swedish company with substantial insider ownership, recently reported a significant increase in Q1 2024 earnings, with net income rising to SEK 333 million from SEK 48 million year-over-year. Despite this growth and no major insider sales in the past three months, challenges persist as interest payments are poorly covered by earnings. The company is expected to become profitable within three years, with revenue growth projected to outpace the Swedish market. However, its forecasted return on equity remains low at 4.6%.
- Click to explore a detailed breakdown of our findings in Wallenstam's earnings growth report.
- Upon reviewing our latest valuation report, Wallenstam's share price might be too optimistic.
Where To Now?
- Dive into all 85 of the Fast Growing Swedish Companies With High Insider Ownership we have identified here.
- Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
- Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Searching for a Fresh Perspective?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Wallenstam might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About OM:WALL B
Reasonable growth potential very low.